{"id":"https://openalex.org/W2026901935","doi":"https://doi.org/10.1517/13543784.14.6.629","title":"TGF-\u03b2 inhibitors for the treatment of cancer","display_name":"TGF-\u03b2 inhibitors for the treatment of cancer","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2026901935","doi":"https://doi.org/10.1517/13543784.14.6.629","mag":"2026901935","pmid":"https://pubmed.ncbi.nlm.nih.gov/16004592"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.14.6.629","doi":"https://doi.org/10.1517/13543784.14.6.629","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.14.6.629","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2026901935"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101627113","display_name":"Michael M. F. Lahn","orcid":"https://orcid.org/0000-0001-9371-0316","observed_orcids":["https://orcid.org/0000-0001-9371-0316"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Lahn","raw_affiliation_strings":["Eli Lilly & Company Research Laboratories, Therapeutic Area Oncology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. mlahn@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company Research Laboratories, Therapeutic Area Oncology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. mlahn@lilly.com","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046051756","display_name":"Susanne Kloeker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susanne Kloeker","raw_affiliation_strings":["Eli Lilly & Company Research Laboratories, Therapeutic Area Oncology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. mlahn@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company Research Laboratories, Therapeutic Area Oncology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. mlahn@lilly.com","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071272010","display_name":"Brandi Berry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brandi S Berry","raw_affiliation_strings":["Eli Lilly & Company Research Laboratories, Therapeutic Area Oncology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. mlahn@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company Research Laboratories, Therapeutic Area Oncology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. mlahn@lilly.com","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":0.7939,"has_fulltext":false,"cited_by_count":90,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.5987521,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"14","issue":"6","first_page":"629","last_page":"643"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13437","display_name":"Mechanisms of cancer metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tgf-beta-inhibitors","display_name":"TGF-\u03b2 inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9679999947547913},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9300000071525574},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/toxicology","display_name":"toxicology","score":0.7260000109672546},{"id":"https://openalex.org/keywords/carcinogenesis","display_name":"carcinogenesis","score":0.8230000138282776},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.7607714533805847},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.70417320728302},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5633108615875244},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.516363263130188},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4709908366203308},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4626406729221344},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.36689141392707825},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3458820581436157},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34017521142959595},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3233473300933838},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22251299023628235}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.14.6.629","doi":"https://doi.org/10.1517/13543784.14.6.629","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.14.6.629","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:16004592","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16004592","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":116,"referenced_works":["https://openalex.org/W41064495","https://openalex.org/W67798439","https://openalex.org/W98903016","https://openalex.org/W123830685","https://openalex.org/W1480727199","https://openalex.org/W1487581481","https://openalex.org/W1494416455","https://openalex.org/W1503228526","https://openalex.org/W1524950168","https://openalex.org/W1532872348","https://openalex.org/W1539607590","https://openalex.org/W1556377955","https://openalex.org/W1561853258","https://openalex.org/W1564833623","https://openalex.org/W1565561072","https://openalex.org/W1568609601","https://openalex.org/W1582453029","https://openalex.org/W1694823993","https://openalex.org/W1828456061","https://openalex.org/W1930083400","https://openalex.org/W1964513396","https://openalex.org/W1965790286","https://openalex.org/W1966300079","https://openalex.org/W1970708612","https://openalex.org/W1976123775","https://openalex.org/W1977037035","https://openalex.org/W1979877257","https://openalex.org/W1980791428","https://openalex.org/W1983628734","https://openalex.org/W1985929046","https://openalex.org/W1986471913","https://openalex.org/W1987301388","https://openalex.org/W1987449859","https://openalex.org/W1989410511","https://openalex.org/W1992252639","https://openalex.org/W2006264351","https://openalex.org/W2009629707","https://openalex.org/W2012124753","https://openalex.org/W2015685375","https://openalex.org/W2015959969","https://openalex.org/W2024060364","https://openalex.org/W2026428548","https://openalex.org/W2026522493","https://openalex.org/W2030798978","https://openalex.org/W2032622848","https://openalex.org/W2034185792","https://openalex.org/W2034552950","https://openalex.org/W2036044975","https://openalex.org/W2037038224","https://openalex.org/W2039275948","https://openalex.org/W2039347592","https://openalex.org/W2039400831","https://openalex.org/W2040074251","https://openalex.org/W2044069347","https://openalex.org/W2044495695","https://openalex.org/W2051282218","https://openalex.org/W2052562309","https://openalex.org/W2053131178","https://openalex.org/W2054159263","https://openalex.org/W2056088597","https://openalex.org/W2058006748","https://openalex.org/W2063980632","https://openalex.org/W2068771276","https://openalex.org/W2069524101","https://openalex.org/W2072139631","https://openalex.org/W2073241458","https://openalex.org/W2073473087","https://openalex.org/W2074463323","https://openalex.org/W2077715760","https://openalex.org/W2079517510","https://openalex.org/W2087521849","https://openalex.org/W2092347182","https://openalex.org/W2094165314","https://openalex.org/W2094663408","https://openalex.org/W2096527499","https://openalex.org/W2096662041","https://openalex.org/W2097829282","https://openalex.org/W2101314011","https://openalex.org/W2104638995","https://openalex.org/W2105683352","https://openalex.org/W2105863720","https://openalex.org/W2110094917","https://openalex.org/W2114973326","https://openalex.org/W2116062997","https://openalex.org/W2117814548","https://openalex.org/W2118650242","https://openalex.org/W2118857294","https://openalex.org/W2118916648","https://openalex.org/W2119491066","https://openalex.org/W2124887937","https://openalex.org/W2129127258","https://openalex.org/W2129505749","https://openalex.org/W2131211068","https://openalex.org/W2131610677","https://openalex.org/W2134638467","https://openalex.org/W2136358097","https://openalex.org/W2136592357","https://openalex.org/W2143467222","https://openalex.org/W2148046607","https://openalex.org/W2163220652","https://openalex.org/W2163797065","https://openalex.org/W2164236607","https://openalex.org/W2164904188","https://openalex.org/W2168476587","https://openalex.org/W2169237074","https://openalex.org/W2189105300","https://openalex.org/W2225532122","https://openalex.org/W2226515800","https://openalex.org/W2262976102","https://openalex.org/W2277013638","https://openalex.org/W2317138671","https://openalex.org/W2406383826","https://openalex.org/W2441471431","https://openalex.org/W2568732726","https://openalex.org/W2604431835","https://openalex.org/W4302031496"],"related_works":["https://openalex.org/W3044762644","https://openalex.org/W4412415792","https://openalex.org/W3123188618","https://openalex.org/W3112064419","https://openalex.org/W2015959969","https://openalex.org/W126692371","https://openalex.org/W2985438631","https://openalex.org/W2089857483","https://openalex.org/W2017410696","https://openalex.org/W3030002687"],"abstract_inverted_index":{"Advances":[0],"in":[1,10,68,76],"understanding":[2],"the":[3,15,40,56,62,79],"role":[4],"of":[5,17,25,43,45,55,59,65],"transforming":[6],"growth":[7],"factor":[8],"(TGF)-beta":[9],"tumorigenesis":[11],"have":[12,28],"led":[13],"to":[14],"development":[16,44],"TGF-beta":[18,26,48,60,66,74,86],"inhibitors":[19,27,75],"for":[20],"cancer":[21],"treatment.":[22],"Three":[23],"platforms":[24],"evolved:":[29],"antisense":[30],"oligonucleotides,":[31],"monoclonal":[32,83],"antibodies":[33,84],"and":[34,78],"small":[35],"molecules.":[36],"In":[37],"this":[38],"review,":[39],"current":[41],"stage":[42],"each":[46],"known":[47,63],"inhibitor":[49],"will":[50,87],"be":[51,88],"discussed.":[52],"As":[53],"part":[54],"risk/benefit":[57],"assessment":[58],"inhibitors,":[61],"effects":[64],"deficiency":[67],"mice,":[69],"non-clinical":[70],"toxicology":[71],"studies":[72,81],"with":[73,82],"rats,":[77],"clinical":[80],"against":[85],"summarised.":[89]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2026901935","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
